These authors contributed equally.
Delineation of 15q13.3 microdeletions
Article first published online: 9 FEB 2010
© 2010 John Wiley & Sons A/S
Volume 78, Issue 2, pages 149–161, August 2010
How to Cite
Masurel-Paulet, A., Andrieux, J., Callier, P., Cuisset, J., Le Caignec, C., Holder, M., Thauvin-Robinet, C., Doray, B., Flori, E., Alex-Cordier, M., Beri, M., Boute, O., Delobel, B., Dieux, A., Vallee, L., Jaillard, S., Odent, S., Isidor, B., Beneteau, C., Vigneron, J., Bilan, F., Gilbert-Dussardier, B., Dubourg, C., Labalme, A., Bidon, C., Gautier, A., Pernes, P., Pinoit, J., Huet, F., Mugneret, F., Aral, B., Jonveaux, P., Sanlaville, D. and Faivre, L. (2010), Delineation of 15q13.3 microdeletions. Clinical Genetics, 78: 149–161. doi: 10.1111/j.1399-0004.2010.01374.x
- Issue published online: 6 JUL 2010
- Article first published online: 9 FEB 2010
- Received 8 September 2009, revised and accepted for publication 4 January 2010
- 15q13.3 microdeletion;
- homozygous deletion;
- incomplete penetrance;
- variable expressivity
Masurel-Paulet A, Andrieux J, Callier P, Cuisset JM, Le Caignec C, Holder M, Thauvin-Robinet C, Doray B, Flori E, Alex-Cordier MP, Beri M, Boute O, Delobel B, Dieux A, Vallee L, Jaillard S, Odent S, Isidor B, Beneteau C, Vigneron J, Bilan F, Gilbert-Dussardier B, Dubourg C, Labalme A, Gautier A, Pernes P, Bidon C, Pinoit JM, Huet F, Mugneret F, Aral B, Jonveaux P, Sanlaville D, Faivre L. Delineation of 15q13.3 microdeletions.
The increasing use of array-comparative genomic hybridization (array-CGH) to identify copy number variations (CNVs) in patients with developmental delay (DD), mental retardation and/or dysmorphic features has allowed the recent recognition of numerous genomic imbalances, including the 15q13.3 microdeletion. Patients with this microdeletion generally present with relatively consistent breakpoints at BP4 and BP5, which include the CHRNA7 gene. About 100 index cases have been reported since the first publication in 2008. This large number of patients ascertained through highly variable samples has been necessary to describe the full phenotypic spectrum of this microdeletion, ranging from mental retardation with dysmorphic features, epilepsy, neuropsychiatric disturbances with or without cognitive impairment to complete absence of anomalies. Here, we describe a collaborative study reporting a new cohort of 12 index patients and 13 relatives carrying a heterozygous BP4–BP5 microdeletion out of a series of 4625 patients screened by array-CGH for DD. We confirm the clinical expressivity of the disease as well as the incomplete penetrance in seven families. We showed through a review of the literature that males are more likely to be symptomatic. Sequence analysis of CHRNA7 yielded no data to support the unmasking of recessive variants as a cause of phenotypic variability. We also report the first patient carrying a 15q13.3 homozygous microdeletion inherited from both parents. He had severe epileptic encephalopathy with retinopathy, autistic features and choreoathetosis. Besides the classical ∼1.5 Mb BP4–BP5 microdeletion, we also describe three index patients and two relatives with a smaller 500 kb microdeletion, including the CHRNA7 gene.